Czeslaw
Czeslaw Golkowski, Ithaca, NY US
Patent application number | Description | Published |
---|---|---|
20110027125 | Free Radical Sterilization System and Method - A free radical decontamination method and system. The system is comprised of a chamber defining a region, and a generator for generating free radical reach effluent from a free radical electric generator and hydrogen peroxide solution with water. A closed loop circulating system is provided for supplying the mixture of free radicals from the electric generator mixed with the hydrogen peroxide solution in the form of the effluent to the chamber. | 02-03-2011 |
20120277662 | Free Radical Sterilization System and Method - A free radical sterilization system having a chamber defining a region, and a generator for generating free radical reach effluent from a free radical electric generator and/or a vaporizer. A closed loop circulating system without a free-radical destroyer is provided for supplying the mixture of free radicals from the electric generator mixed with the hydrogen peroxide solution in the form of the effluent to the chamber. The free-radical sterilization system is used in sterilizing items in the chamber and, with an open-bottomed wound chamber, in treating wounds on a body. | 11-01-2012 |
Czeslaw Lugowski, Wroclaw PL
Patent application number | Description | Published |
---|---|---|
20130266971 | POLYSACCHARIDE AND DERIVATIVES THEREOF, SHOWING AFFINITY TO FICOLIN-3, METHOD OF PREPARATION AND USE - The invention relates to bacterial lipopolysaccharide and its components, especially native and chemically modified polysaccharides isolated from | 10-10-2013 |
Czeslaw Siemaszko, Ottawa CA
Patent application number | Description | Published |
---|---|---|
20100064362 | SYSTEMS AND METHODS FOR VOIP NETWORK SECURITY - According to an aspect of the present invention there is provided a VoIP asset discovery system for discovering and identifying VoIP assets on a VoIP network, the asset discovery system comprising an IP address module for determining at least one IP address to discover, a port scanner for scanning VoIP specific ports of the received IP addresses, a service detection module for detecting a VoIP service at the received IP addresses. The asset discovery system further comprises a fingerprinting module for fingerprinting VoIP applications based on responses received to specific queries and a correlation module for correlating the information from the port scanner module, the service detection module, and the fingerprinting module to identify the instances of the discovered assets. | 03-11-2010 |
Czeslaw Wojtyczka, Brampton CA
Patent application number | Description | Published |
---|---|---|
20100111675 | FAN CASE FOR TURBOFAN ENGINE - A gas turbine engine rotor containment structure comprises an inner structurally supporting case having an inner surface positioned adjacent to a gas turbine engine rotor component to be contained. A layer of acoustic material is wrapped around and bounded to a radially outer surface of the inner case. A thin walled outer ring is bounded to a radially outer surface the layer of acoustic material. A layer of fibrous containment material surrounds a radially outer surface of the outer ring. | 05-06-2010 |
20110286839 | FAN CASE WITH RUB ELEMENTS - A turbofan engine comprising an annular inner wall surrounding tips of the fan blades, a layer of insulating material surrounding the inner wall, and an outer casing including an annular outer wall surrounding the insulating material and concentric to the inner wall and at least two annular rub elements extending radially inwardly from the outer wall through only part of a radial thickness of the layer of insulating material, at least two of the rub elements being in axial alignment with the blade tips at every point around a circumference of the fan, each rub element having a radially inner end spaced apart from the inner wall and made of a material harder than that of the blades, and a containment fabric layer wrapped around a support structure of the outer wall. | 11-24-2011 |
Czeslaw Wojtyczka, Mississauga CA
Patent application number | Description | Published |
---|---|---|
20130156558 | ANNULAR GAS TURBINE ENGINE CASE AND METHOD OF MANUFACTURING - The method is used for making an annular gas turbine engine case from a preform. The method comprises comprising flowforming at least one section of the preform, and then outwardly bending at least one portion of the perform. | 06-20-2013 |
Czeslaw Wychowski, Meurchin FR
Patent application number | Description | Published |
---|---|---|
20080220410 | METHOD FOR REPLICATING THE HEPATITIS C VIRUS - The invention concerns the use of cells capable of carrying out a process of prenylation of proteins coded by the hepatitis C virus (HCV) genome, such as prenylation of the NS5A protein, for replicating and, if required, the production of HCV or derivative viable mutants, in a suitable culture medium. | 09-11-2008 |
20100159467 | METHOD FOR REPLICATING THE HEPATITIS C VIRUS - A process for screening anti-HCV agents, including the steps of introducing a compound to be tested for its anti-HCV properties with transformed Vero/6418 cells, having a nucleic acid selected from the group consisting of a nucleic acid coding for the structural and non-structural proteins of the HCV, a nucleic acid coding for the non-structural proteins of the HCV, and a replicon containing a resistance gene to an antibiotic and a nucleotide sequence coding for the non-structural proteins of the HCV; extracting total RNA of the cells; and analyzing any reduction of the rate, of synthesis of the RNA of the HCV of the cells relative to a control value corresponding to the rates of synthesis of the RNAs of the HCV of the cells in the absence of the tested compound. | 06-24-2010 |
20140088184 | Use of Epigallocatechin Gallate as an Antiviral Agent against infections by the Hepatitis C Virus - The present invention relates to a flavonoid compound having the formula I, where R3, R5 and/or R7 is a group having the formula II, or R1 and R2 are both OH groups, or to one of the pharmaceutically acceptable salts or esters thereof, for use as an antiviral agent in the treatment and/or prevention of a hepatitis C virus (HCV) infection. The invention also relates to an ex vivo method for reducing the infectivity of HCV or for inactivating HCV, including a step of contacting said hepatitis C virus with a compound having the formula (I). | 03-27-2014 |